Abeona: BLA Submission Of EB-101 Gets The Ball Rolling (NASDAQ:ABEO)

Chemical instrument glassware

ximushushu/iStock via Getty Images

Abeona Therapeutics (NASDAQ:ABEO) is a good speculative biotech play to look into. The reason why I state that is because it is gearing up to file a Biologics Licensing Application [BLA] to the FDA of EB-101 for

Read more here: Source link